Page 13 - Service Testing News Today

By Colin Kellaher INmune Bio on Tuesday said the U.S. Food and Drug Administration has lifted the full clinical hold on the immunology company's Alzheimer's...

By Dean Seal Shares of Iterum Therapeutics soared after the company reported positive results from a clinical trial of its treatment for urinary tract...

By Rob Curran Shares of Kura Oncology were higher after the cancer-drug developer reported promising results from an early-stage trial of a leukemia drug....

Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The

/PRNewswire/ -- The global management system certification market is projected to grow from USD 40.0 billion in 2024 to USD 49.5 billion by 2029, registering a...

By Chris Wack LIXTE Biotechnology shares were up 14% to $2.27 after the company said it has dosed the first patient in a Phase 1b/2 clinical trial to assess...

By Adam L. Cataldo Shares of Corbus Pharmaceuticals Holdings more than tripled on Friday after it reported positive results from its first-in-human study of...

By Rob Curran Vera Therapeutics rose after the biotech firm said one of its product candidates showed promise in a mid-stage trial on patients with a kidney...

By Helena Smolak Ipsen's phase-three trial of prostate cancer drug Cabometyx yielded positive results, the company said late Monday. The French...

By Denny Jacob Scholar Rock Holding said the Food and Drug Administration cleared its investigational new drug application for its Phase 2 trial of...